🇺🇸 FDA
Patent

US 7713983

Quinazolines useful as modulators of ion channels

granted A61PA61P11/00A61P13/02

Quick answer

US patent 7713983 (Quinazolines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P11/00, A61P13/02, A61P17/02, A61P19/02